Sweeny Nicole
SEC insider (Form 3/4/5 filer). CIK 0001827505. Chief Commercial Officer at KalVista Pharmaceuticals, Inc. (KALV). 18 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in FRAMINGHAM, MA.
Companies Sweeny Nicole has filed insider reports for
- KalVista Pharmaceuticals, Inc. (KALV): Officer, Chief Commercial Officer
Sweeny Nicole
CIK: 0001827505
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KalVista Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jun 11, 2026KALV
KalVista Pharmaceuticals, Inc.
DispositionDirect59.3K shares- - May 26, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect1.5K shares at avg. $26.78$40K - May 22, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect5K shares- - May 22, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect1.9K shares at avg. $26.78$50K - May 21, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect6.3K shares- - Apr 17, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect1.9K shares at avg. $20.22$38K - Apr 16, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect6.3K shares- - Feb 23, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect4K shares at avg. $15.57$62K - Feb 22, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect5K shares- - Feb 21, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect6.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | Disposition | 59,291 | - | $0 | Direct |
| May 26, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 1,489 | $26.78 | $39,872 | Direct |
| May 22, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 5,000 | - | $0 | Direct |
| May 22, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 1,861 | $26.78 | $49,846 | Direct |
| May 21, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 6,250 | - | $0 | Direct |
| Apr 17, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 1,862 | $20.22 | $37,643 | Direct |
| Apr 16, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 6,250 | - | $0 | Direct |
| Feb 23, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 3,975 | $15.57 | $61,878 | Direct |
| Feb 22, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 5,000 | - | $0 | Direct |
| Feb 21, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 6,250 | - | $0 | Direct |
1-10 of 18 transactions